LLY has declined 10.6% this month after disappointing third-quarter results. The drug maker has seen strong success in recent ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Tesla remains a significant holding for The Future Fund despite position reductions, according to Managing Partner Gary Black ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...

Conditions are getting a bit more challenging for the drugmaker.

Even a juggernaut like Eli Lilly (NYSE: LLY) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat, ...

Shares of Nvidia rallied to a record high on Thursday, making the chipmaker the first company in history to surpass a stock ...

Nvidia's stock market value ended the day at $3.65 trillion, beating Apple's record closing market capitalization of $3.57 ...

Another issue for investors is that Eli Lilly adjusted its guidance for the year, now projecting its adjusted EPS to fall ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Novo Nordisk reports earnings Wednesday morning, with sales of blockbuster weight-loss drugs Ozempic and Wegovy expected to continue driving the Danish drugmaker's results higher.